CompletedPhase 4NCT02052024

Myobloc Atrophy Study

Studying Malignant vascular tumor

Last synced from ClinicalTrials.gov May 12, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Georgetown University
Principal Investigator: Fernando Pagan, MD, MD
MedStar Georgetown University Hospital
Intervention: Botox(drug)
Enrollment: 10 enrolled
Eligibility: 18 years · All sexes
Timeline: 2014 – 2015

Study locations (1)

Medstar Georgetown University Hospital, Washington D.C., District of Columbia, United States

Collaborators

Solstice Neurosciences

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02052024 on ClinicalTrials.gov

Other trials for Malignant vascular tumor

Additional recruiting or active studies for the same condition.

RECRUITINGPHASE3NCT07582432
A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma
Grifols Biologicals, LLC

See all trials for Malignant vascular tumor →

← Back to all trials